Table: Sawai Pharmaceutical -2015/16 parent results
May 12 (Reuters)-
Sawai Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 122.81 104.68
(+17.3 pct) (+17.7 pct)
Operating 22.74 20.25
(+12.3 pct) (+9.0 pct)
Recurring 22.69 20.29
(+11.8 pct) (+8.7 pct)
Net 17.01 13.88
(+22.6 pct) (+16.0 pct)
EPS 461.71 yen 377.57 yen
EPS Diluted 461.40 yen 377.16 yen
Ann Div 120.00 yen 105.00 yen 130.00 yen
-Q2 Div 55.00 yen 50.00 yen 65.00 yen
-Q4 Div 65.00 yen 55.00 yen 65.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)